Noxopharm Ltd V.NOX

Primary Symbol: NOXOF

Healthcare Biotechnology

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.

OTCPK:NOXOF - Post by User

Noxopharm Ltd > NOX issues stock options - Aug. 29

<< Previous

Bullboard Posts

Next >>

Post by alixx11on Aug 29, 2013 8:04pm

196 Views

Post# 21707999

NOX issues stock options - Aug. 29

Not sure if this was necessary:-/

Niogold announces that that it has granted an aggregate of 1,800,000 incentive stock options exercisable at $0.20 and 200,000 incentive stock options exercisable at $0.30 for a period of five years to directors, officers, employees and consultants of the Company.

https://www.otcmarkets.com/otciq/ajax/showNewsReleaseDocumentById.pdf?id=1589371855